HT
LEGN icon

Headlands Technologies’s Legend Biotech LEGN Stock Holding History

Headlands Technologies’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$894K Buy
49,428
+14,686
+42% +$280K 0.1% 230
2025
Q4 		$755K Buy
+34,742
New +$995K 0.06% 316
2025
Q1 		– Sell
-11,935
Closed -$388K – 1356
2024
Q4 		$388K Buy
11,935
+11,373
+2,024% +$471K 0.04% 396
2024
Q3 		$27.4K Buy
+562
New +$29.9K ﹤0.01% 902

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Headlands Technologies's LEGN Position: Q1 2026 in Review

Headlands Technologies increased its Legend Biotech (LEGN) stake by 42% in Q1 2026, buying an estimated $280K and bringing the position to 49,428 shares worth $894K. The position accounts for 0.1% of the portfolio, ranked #230.

Headlands Technologies first reported a position in LEGN in Q3 2024 and has held it in 4 quarters since. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Headlands Technologies held 49,428 shares of Legend Biotech worth $894K as of Q1 2026.
  • Headlands Technologies bought 14,686 Legend Biotech shares in Q1 2026, an estimated $280K.
  • Legend Biotech made up 0.1% of Headlands Technologies's portfolio in Q1 2026, its #230 holding.
  • Headlands Technologies first reported a position in Legend Biotech in Q3 2024 and has held it in 4 quarters since.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.